Biotech Values

[DewDiligence]

RVNC—In these kinds of deals, the manufacturer (RVNC in this instance) generally gets paid a contractual price on shipments of drug that includes a modest mark-up to the actual production cost. This is separate from the royalty on sales.

There isn’t enough information in the RVNC-Fosun PR to determine exactly how this will work, but there will probably be more detail in an upcoming SEC filing.